The dose-response of aerobic exercise after stroke on cardiorespiratory fitness: A phase 1 dose-escalation trial

被引：0
|
作者：
Galloway, Margaret [1 ,2 ,3 ]
Marsden, Di [2 ,4 ]
Callister, Robin [2 ,5 ,6 ]
Nilsson, Michael [2 ,7 ]
Erickson, Kirk [8 ]
English, Coralie [1 ,2 ,3 ]
机构：
[1] Univ Newcastle, Sch Hlth Sci, Newcastle, NSW, Australia
[2] Hunter Med Res Inst, Newcastle, NSW, Australia
[3] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia
[4] Hunter New England Local Hlth Dist, Newcastle, NSW, Australia
[5] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW, Australia
[6] Univ Newcastle, Prior Res Ctr Phys Act & Nutr, Newcastle, NSW, Australia
[7] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia
[8] Univ Pittsburgh, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF STROKE | 2019年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [31] Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias
    Zeidan, Amer M.
    Ricklis, Rebecca M.
    Carraway, Hetty E.
    Yun, Hyun D.
    Greer, Jacqueline M.
    Smith, B. Douglas
    Levis, Mark J.
    McDevitt, Michael A.
    Pratz, Keith W.
    Showel, Margaret M.
    Gladstone, Douglas E.
    Gore, Steven D.
    Karp, Judith E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (02) : 198 - 207
  • [32] A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma
    Chiorean, E. Gabriela
    Dragovich, Tomislav
    Hamm, John
    Langmuir, Virginia K.
    Kroll, Stewart
    Jung, Donald T.
    Colowick, Alan B.
    Tidmarsh, George F.
    Loehrer, Patrick J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (06) : 1019 - 1026
  • [33] ASTIN: a Bayesian adaptive dose-response trial in acute stroke
    Grieve, AP
    Krams, M
    CLINICAL TRIALS, 2005, 2 (04) : 340 - 351
  • [34] Safety and immunogenicity in a phase I dose-escalation BPV-1VLP vaccine trial in horses
    Kirnbauer, R.
    Brandt, S.
    Shafti-Keramat, S.
    Hainisch, E. K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 17 - 18
  • [35] Phase 1 Dose-Escalation Trial of Tremelimumab Plus Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    Rini, Brian I.
    Stein, Mark
    Shannon, Pat
    Eddy, Simantini
    Tyler, Allison
    Stephenson, Joe J., Jr.
    Catlett, Lone
    Huang, Bo
    Healey, Diane
    Gordon, Michael
    CANCER, 2011, 117 (04) : 758 - 767
  • [36] A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma
    E. Gabriela Chiorean
    Tomislav Dragovich
    John Hamm
    Virginia K. Langmuir
    Stewart Kroll
    Donald T. Jung
    Alan B. Colowick
    George F. Tidmarsh
    Patrick J. Loehrer
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 1019 - 1026
  • [37] Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
    Falchook, Gerald S.
    Lewis, Karl D.
    Infante, Jeffrey R.
    Gordon, Michael S.
    Vogelzang, Nicholas J.
    DeMarini, Douglas J.
    Sun, Peng
    Moy, Christopher
    Szabo, Stephen A.
    Roadcap, Lori T.
    Peddareddigari, Vijay G. R.
    Lebowitz, Peter F.
    Le, Ngocdiep T.
    Burris, Howard A., III
    Messersmith, Wells A.
    O'Dwyer, Peter J.
    Kim, Kevin B.
    Flaherty, Keith
    Bendell, Johanna C.
    Gonzalez, Rene
    Kurzrock, Razelle
    Fecher, Leslie A.
    LANCET ONCOLOGY, 2012, 13 (08): : 782 - 789
  • [38] Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial
    Naik, Haley B.
    Cowen, Edward W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (03) : 743 - 744
  • [39] A phase I dose-escalation trial of GliaSite brachytherapy for recurrent glioblastoma multiforme.
    Mikkelsen, T
    Kleinberg, L
    Judy, K
    Ye, X
    Stieber, V
    Desideri, S
    Fisher, JD
    Grossman, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 126S - 126S
  • [40] Optimal phase I dose-escalation trial designs in oncology-A simulation study
    Gerke, Oke
    Siedentop, Harald
    STATISTICS IN MEDICINE, 2008, 27 (26) : 5329 - 5344
12345